Corcept Therapeutics Incorporated Analysis
| Analyst Ratings |
|
Average Target Price
|
34.20
|
|
Average Rating
|
4.40
|
|
# Strong Buys
|
3
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.23
|
0.30
|
0.07
|
30.43%
|
|
2022-06-30
|
0.24
|
0.24
|
0.00
|
0.00%
|
|
2022-03-31
|
0.24
|
0.20
|
-0.04
|
-16.67%
|
|
2021-12-31
|
0.22
|
0.26
|
0.04
|
18.18%
|
|
2021-09-30
|
0.20
|
0.24
|
0.04
|
20.00%
|
|
2021-06-30
|
0.16
|
0.21
|
0.05
|
31.25%
|
|
2021-03-31
|
0.21
|
0.18
|
-0.03
|
-14.29%
|
|
2020-12-31
|
0.19
|
0.20
|
0.01
|
5.26%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
0.74
|
|
2021-12-31
|
0.89
|
|
2020-12-31
|
0.85
|
|
2019-12-31
|
0.78
|
|
2018-12-31
|
0.60
|
|
2017-12-31
|
0.42
|
|
2016-12-31
|
0.07
|
|
2015-12-31
|
-0.07
|
|
2014-12-31
|
-0.31
|
|
2013-12-31
|
-0.45
|
|
2012-12-31
|
-0.41
|
|
2011-12-31
|
-0.40
|
|
2010-12-31
|
-0.39
|
|
2009-12-31
|
-0.39
|
|
2008-12-31
|
-0.43
|
|
2007-12-31
|
-0.34
|
|
2006-12-31
|
-1.09
|
|
2005-12-31
|
-0.88
|
|
2004-12-31
|
-0.88
|